Chemical Structure : NDI-031407
货号: PC-72038Not For Human Use, Lab Use Only.
NDI-031407 (NDI 031407) is a novel potent, selective TYK2 inhibitor with IC50 of 0.21 nM in radiometric assays, 20 fold selectivity over JAK3 (4.2 nM), 147 fold for JAK2 (31 nM), and 220 fold for JAK1 (46 nM).
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NDI-031407 (NDI 031407) is a novel potent, selective TYK2 inhibitor with IC50 of 0.21 nM in radiometric assays, 20 fold selectivity over JAK3 (4.2 nM), 147 fold for JAK2 (31 nM), and 220 fold for JAK1 (46 nM).
NDI-031407 has high potency in cell line and primary cell assays for TYK2-dependent cytokines (IL-12, IC50=118 nM) over TYK2-independent cytokines (GM-CSF).
NDI-031407 blocks IL-23–induced STAT3 phosphorylation and IL-17A production in human CD4+ T cells.
NDI-031407 inhibits disease progression in the SKG model of Spondyloarthritis (SpA).
NDI-031407 suppresses systemic IL-23–induced type 3 immunity in vivo.
分子量 | ||
分子式 | ||
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
|
1. Eric Gracey, et al. J Clin Invest. 2020 Apr 1;130(4):1863-1878.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright